NM_001126108.2:c.2598C>T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001126108.2(SLC12A3):​c.2598C>T​(p.Gly866Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 1,613,402 control chromosomes in the GnomAD database, including 9,953 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.096 ( 890 hom., cov: 31)
Exomes 𝑓: 0.10 ( 9063 hom. )

Consequence

SLC12A3
NM_001126108.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.55

Publications

25 publications found
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SLC12A3 Gene-Disease associations (from GenCC):
  • Gitelman syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 16-56894607-C-T is Benign according to our data. Variant chr16-56894607-C-T is described in ClinVar as Benign. ClinVar VariationId is 255887.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.219 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A3NM_001126108.2 linkc.2598C>T p.Gly866Gly synonymous_variant Exon 22 of 26 ENST00000563236.6 NP_001119580.2 P55017-1
SLC12A3NM_000339.3 linkc.2625C>T p.Gly875Gly synonymous_variant Exon 22 of 26 NP_000330.3 P55017-2
SLC12A3NM_001126107.2 linkc.2622C>T p.Gly874Gly synonymous_variant Exon 22 of 26 NP_001119579.2 P55017-3
SLC12A3NM_001410896.1 linkc.2595C>T p.Gly865Gly synonymous_variant Exon 22 of 26 NP_001397825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A3ENST00000563236.6 linkc.2598C>T p.Gly866Gly synonymous_variant Exon 22 of 26 1 NM_001126108.2 ENSP00000456149.2 P55017-1
SLC12A3ENST00000438926.6 linkc.2625C>T p.Gly875Gly synonymous_variant Exon 22 of 26 1 ENSP00000402152.2 P55017-2
SLC12A3ENST00000566786.5 linkc.2622C>T p.Gly874Gly synonymous_variant Exon 22 of 26 1 ENSP00000457552.1 P55017-3
SLC12A3ENST00000262502.5 linkc.2595C>T p.Gly865Gly synonymous_variant Exon 22 of 26 5 ENSP00000262502.5 J3QSS1

Frequencies

GnomAD3 genomes
AF:
0.0964
AC:
14652
AN:
151988
Hom.:
885
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0494
Gnomad AMI
AF:
0.113
Gnomad AMR
AF:
0.171
Gnomad ASJ
AF:
0.137
Gnomad EAS
AF:
0.231
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.0933
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.0913
Gnomad OTH
AF:
0.107
GnomAD2 exomes
AF:
0.126
AC:
31608
AN:
251316
AF XY:
0.123
show subpopulations
Gnomad AFR exome
AF:
0.0485
Gnomad AMR exome
AF:
0.218
Gnomad ASJ exome
AF:
0.137
Gnomad EAS exome
AF:
0.225
Gnomad FIN exome
AF:
0.0986
Gnomad NFE exome
AF:
0.0897
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.104
AC:
151924
AN:
1461296
Hom.:
9063
Cov.:
32
AF XY:
0.105
AC XY:
76383
AN XY:
726972
show subpopulations
African (AFR)
AF:
0.0435
AC:
1456
AN:
33472
American (AMR)
AF:
0.216
AC:
9664
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.135
AC:
3519
AN:
26120
East Asian (EAS)
AF:
0.252
AC:
10019
AN:
39684
South Asian (SAS)
AF:
0.153
AC:
13223
AN:
86210
European-Finnish (FIN)
AF:
0.0962
AC:
5140
AN:
53408
Middle Eastern (MID)
AF:
0.106
AC:
610
AN:
5768
European-Non Finnish (NFE)
AF:
0.0914
AC:
101574
AN:
1111546
Other (OTH)
AF:
0.111
AC:
6719
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
7061
14121
21182
28242
35303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3940
7880
11820
15760
19700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0964
AC:
14664
AN:
152106
Hom.:
890
Cov.:
31
AF XY:
0.101
AC XY:
7476
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.0493
AC:
2047
AN:
41496
American (AMR)
AF:
0.171
AC:
2617
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.137
AC:
476
AN:
3466
East Asian (EAS)
AF:
0.230
AC:
1189
AN:
5162
South Asian (SAS)
AF:
0.160
AC:
773
AN:
4818
European-Finnish (FIN)
AF:
0.0933
AC:
989
AN:
10598
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0913
AC:
6206
AN:
67978
Other (OTH)
AF:
0.110
AC:
231
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
666
1331
1997
2662
3328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0953
Hom.:
634
Bravo
AF:
0.0997
Asia WGS
AF:
0.184
AC:
637
AN:
3478
EpiCase
AF:
0.0916
EpiControl
AF:
0.0953

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hypokalemia-hypomagnesemia Benign:4
Jun 29, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
5.0
DANN
Benign
0.63
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.24
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.24
Position offset: 35

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5804; hg19: chr16-56928519; COSMIC: COSV52635248; API